ninety-six patients with reversible airways disease and a history of nocturnal asthma completed a four-week open-label study that compared the effectiveness of uniphyl tablets ( the purdue frederick company , norwalk , connecticut ) administered once daily in the morning or the evening with twice-daily baseline theophylline therapy .
C0700814
uniphyl
C0039771
theophylline